31 December 2024 - The MHRA has today approved the medicine tarlatamab (Imdyllytra) to treat adult patients with small cell lung cancer that has spread throughout the lungs and/or to other parts of the body.

This approval has been granted under Project Orbis, an innovative programme that allows participating regulators to review and approve applications for promising cancer treatments quickly and efficiently.

Read UK Government press release